Beijing Hainayourong Investment Management Co., Ltd., commonly referred to as Hairong, is an investment management corporation based in Beijing, China. Founded in 2012, Hairong focus on the asset investment and management in the medical treatment and health field. Also, Hairong is a special member of China Securities Industry Association.
The founders and partners of Hairong graduated from the famous universities in China, like the people’s Bank of China Graduate Student Department, the Beijing University, the Renmin University of China, the China Union Medical College and so on. Because of the higher education and numerous experiences, Hairong always has advance consciousness and deep understand of the medical field.
The core business of the Hairong includes venture capital, growth investment, and merger and acquisition. Also, Hairong provides consulting services for the companies and agents that are interested in the medical treatment field. In addition, Hairong can provide the services about the trade of medical, the consultation of equipment, and establishing of sales team.
By the end of June 2021, Hairong had completed 15 investments (like Tibet Aim Pharmaceutical Company) include a directional add-issuance (Albao Pharmaceutical Industry), buyout the Xizang Hairong Tangguo Pharmaceutical Company, and follows up many outstanding company.
“By relying on the development of the world's largest health consumer market in the next 30 years, it will promote the innovation of medical technology, lead the development of health industry and bring higher returns to investors at lower risk. " Investment concept, " focusing on medical care, creating wealth, service society "as the vision, through the Hairong’s operation and management promotion, and investment enterprises to grow together, and business partners to share happiness.